看似康复的COVID-19患者中SARS-CoV-2持续感染
该研究对27例看似康复但临床持续恶化、连续鼻咽拭子或肺泡灌洗液SARS-CoV-2 RNA阴性的COVID-19患者进行尸检分析。尽管分子检测阴性,81%患者存在弥漫或局灶性间质性肺炎,67%有微/大血管血栓,且支气管软骨软骨细胞和支气管旁腺上皮细胞中检出病毒抗原(70%),提示SARS-CoV-2感染可远长于PCR阴性所提示的时间。
要点
- 连续PCR阴性的康复期COVID-19患者仍可能存在持续肺部感染。
- 尸检常见间质性肺炎、纤维化及血栓,类似急性COVID-19病理。
- 支气管软骨细胞和腺上皮细胞是病毒持续感染的特定细胞类型。
核心结论
- SARS-CoV-2感染可持续显著长于标准PCR阴性检测所提示的时间,并特异性感染肺内特定细胞类型。
- 持续感染细胞是否在长COVID中起致病作用尚待研究。
研究设计与样本
- 对27例连续纳入的看似康复但临床持续恶化、连续病毒检测阴性的COVID-19患者进行尸检分析。
- 病毒阴性持续11-300天(平均105.5天),其中3例PCR阴性超过9个月。
主要发现
- 23/27(81%)患者存在弥漫或局灶性间质性肺炎,13例(47%)伴广泛纤维化替代。
- 微和大血管血栓见于67%病例,血管炎24%,呼吸道上皮鳞状化生30%,细胞学异常和合胞体67%,支气管软骨形态异常44%。
- 呼吸道上皮未检出SARS-CoV-2抗原,但70%病例支气管软骨软骨细胞和支气管旁腺上皮细胞检出针对刺突和核衣壳的抗体。
- 19%病例血管周细胞和内皮细胞也呈阳性,组织裂解液定量RT-PCR证实病毒RNA存在。
临床怎么用
- 对PCR阴性但临床持续恶化的COVID-19康复者,应警惕持续肺部感染和类似急性COVID-19的病理改变。
- 病理评估需关注支气管软骨、腺上皮及血管周细胞等特定细胞类型的病毒感染证据。
局限性
- 样本量小(27例),为尸检研究,结论外推需谨慎。
- 持续感染细胞在长COVID中的致病作用尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SARS-CoV-2 infection is clinically heterogeneous, ranging from asymptomatic to deadly. A few patients with COVID-19 appear to recover from acute viral infection but nevertheless progress in their disease and eventually die, despite persistent negativity at molecular tests for SARS-CoV-2 RNA. Here, we performed post-mortem analyses in 27 consecutive patients who had apparently recovered from COVID-19 but had progressively worsened in their clinical conditions despite repeated viral negativity in nasopharyngeal swabs or bronchioalveolar lavage for 11-300 consecutive days (average: 105.5 days). Three of these patients remained PCR-negative for over 9 months. Post-mortem analysis revealed evidence of diffuse or focal interstitial pneumonia in 23/27 (81%) patients, accompanied by extensive fibrotic substitution in 13 cases (47%). Despite apparent virological remission, lung pathology was similar to that observed in acute COVID-19 individuals, including micro- and macro-vascular thrombosis (67% of cases), vasculitis (24%), squamous metaplasia of the respiratory epithelium (30%), frequent cytological abnormalities and syncytia (67%), and the presence of dysmorphic features in the bronchial cartilage (44%). Consistent with molecular test negativity, SARS-CoV-2 antigens were not detected in the respiratory epithelium. In contrast, antibodies against both spike and nucleocapsid revealed the frequent (70%) infection of bronchial cartilage chondrocytes and para-bronchial gland epithelial cells. In a few patients (19%), we also detected positivity in vascular pericytes and endothelial cells. Quantitative RT-PCR amplification in tissue lysates confirmed the presence of viral RNA. Together, these findings indicate that SARS-CoV-2 infection can persist significantly longer than suggested by standard PCR-negative tests, with specific infection of specific cell types in the lung. Whether these persistently infected cells also play a pathogenic role in long COVID remains to be addressed. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
引用
- Bussani R, Zentilin L, Correa R, et al. Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19. J Pathol. 2023. PMID: 36651103. doi:10.1002/path.6035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。